Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Fungi%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22Fungi%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22Fungi%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (58)
1
Predictors and Outcomes of Peritoneal Dialysis (PD)-Related Infections due to Filamentous Molds : Predictors and Outcomes of Peritoneal Dialysis (PD)-Related Infections due to Filamentous Molds
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Predictors and Outcomes of Peritoneal Dialysis (PD)-Related Infections due to Filamentous Molds : Predictors and Outcomes of Peritoneal Dialysis (PD)-Related Infections due to Filamentous Molds
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Study on the characteristics of ICU acquired fungi : Study on the characteristics of ICU acquired fungi
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Study on the characteristics of ICU acquired fungi : Study on the characteristics of ICU acquired fungi
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A study to evaluate F901318 (study drug) for the treatment of invasive fungal infections in patients lacking suitable alternative treatment options. : An open-label single-arm Phase IIb study of F901318 as treatment of invasive fungal infections due to Lomentospora prolificans, Scedosporium spp., Aspergillus spp., and other resistant fungi in patients lacking suitable alternative treatment options. - FORMULA-OLS:F901318,the first orotomide for invasive fungal diseases- an open-label single-arm study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A study to evaluate F901318 (study drug) for the treatment of invasive fungal infections in patients lacking suitable alternative treatment options. : An open-label single-arm Phase IIb study of F901318 as treatment of invasive fungal infections due to Lomentospora prolificans, Scedosporium spp., Aspergillus spp., and other resistant fungi in patients lacking suitable alternative treatment options. - FORMULA-OLS:F901318,the first orotomide for invasive fungal diseases- an open-label single-arm study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Evaluation of a pharmaceutical service for managing minor ailments : INDICA+PRO study: evaluation of a minor ailment service in community pharmacy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Evaluation of a pharmaceutical service for managing minor ailments : INDICA+PRO study: evaluation of a minor ailment service in community pharmacy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
Randomized, single-blinded, placebo-controlled, parallel-group trial to clarify the efficacy of 3 times nebulized Amphotericin B on cough symptoms in chronic cough patients with Bjerkandera adusta cultured : Randomized, single-blinded, placebo-controlled, parallel-group trial to clarify the efficacy of 3 times nebulized Amphotericin B on cough symptoms in chronic cough patients with Bjerkandera adusta cultured - Efficacy of multiple nebulized Amphotericin B on chronic cough cough with Bjerkandera adusta cultured
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
Randomized, single-blinded, placebo-controlled, parallel-group trial to clarify the efficacy of 3 times nebulized Amphotericin B on cough symptoms in chronic cough patients with Bjerkandera adusta cultured : Randomized, single-blinded, placebo-controlled, parallel-group trial to clarify the efficacy of 3 times nebulized Amphotericin B on cough symptoms in chronic cough patients with Bjerkandera adusta cultured - Efficacy of multiple nebulized Amphotericin B on chronic cough cough with Bjerkandera adusta cultured
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
Nächster »
[6]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
58
Aufsätze
58
E-Artikel
58
E-Ressourcen
Zeitschriftentitel
58
WHO International Clinical Trials Registry Plat...
Thema
58
610
54
Study Type: Interventional
30
Recruitment Status: Not yet recruiting
16
Phase: Phase 2
14
Recruitment Status: Authorised-recruitment may ...
12
Medical Condition: invasive fungal infections d...
10
Phase: Phase 3
6
Recruitment Status: Completed
4
Medical Condition: Invasive fungal disease caus...
4
Phase: Phase 1
4
Study Type: Observational
2
Medical Condition: Adenosine deaminase (ADA) de...
2
Medical Condition: Adenosine deaminase (ADA) de...
2
Medical Condition: Candida albicans number of f...
2
Medical Condition: Chronic cough with basidiomy...
2
Medical Condition: Chronic granulomatous diseas...
2
Medical Condition: Cystic Fibrosis (CF) is the ...
2
Medical Condition: Health Condition 1: B449- As...
2
Medical Condition: ICU acquired fungi
2
Medical Condition: Invasive fungal disease caus...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
24
2020-
34
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
58
Englisch
Haven't found what you're looking for?
Wird geladen...